Skip to main content
Premium Trial:

Request an Annual Quote

NY Grants Combimatrix Clinical Lab Permit

NEW YORK (GenomeWeb News) – Combimatrix said today that the New York State Department of Health has given the Irvine, Calif.-based company a clinical laboratory permit to receive specimens for its DNA Array postnatal test from New Yorkers.

The DNA Array tests, offered through Combimatrix's subsidiary Combimatrix Diagnostics, provide a genomic evaluation on newborns for a range of disorders, including autism, mental retardation, and other birth defects. The tests are based on the firm's arrayCGH technology.

The firm said that it now has received clinical lab licenses from all "major states including California, Florida, Pennsylvania, Maryland, and Rhode Island. It also has accreditation from the Centers for Medicare and Medicaid Services' Clinical Laboratory Improvement Amendments program, and from the College of American Pathologists.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.